AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE496.252.95 (+0.6 %)
PREV CLOSE ( ) 493.30
OPEN PRICE ( ) 489.65
BID PRICE (QTY) 496.60 (3)
OFFER PRICE (QTY) 497.60 (14)
VOLUME 9637
TODAY'S LOW / HIGH ( )486.25 499.00
52 WK LOW / HIGH ( )408.95 645
NSE497.505.15 (+1.05 %)
PREV CLOSE( ) 492.35
OPEN PRICE ( ) 490.00
BID PRICE (QTY) 497.00 (4)
OFFER PRICE (QTY) 497.55 (5)
VOLUME 76395
TODAY'S LOW / HIGH( ) 485.55 499.10
52 WK LOW / HIGH ( )409 645.75
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.